Metabolomics Technology Market Size, Share & Forecast 2019-2025

Posted by Rishabh on August 29th, 2019

Orion Market Research (OMR) recently published a market research report on the global metabolomics technology market. The market is segmented on the basis of product & service and application. On the basis of product & services, the market is further segmented into metabolomics instruments and bioinformatics. Furthermore, metabolomics instruments are sub-segmented into chromatography, mass spectrometry, nuclear magnetic resonance spectroscopy, others (capillary electrophoresis, surface-based mass analysis).

A full report of Global Metabolomics Technology Market is available at:https://www.omrglobal.com/industry-reports/metabolomics-technology-market/

Metabolomics is a study to identify and quantify small molecule metabolic products of a biological system. The major techniques which are used for this are mass spectrometry and NMR spectroscopy. The mass spectrometry is used in quantifying known material and to identify the unknown material in the sample. This is an analytical technique used as a metabolomics instrument. This is also used to produce charged particles from the chemical substance. The metabolites exist in biofluids, cells, and tissues and various other. The metabolomics involved mainly the factors of metabolism which can be affected by environmental and genetic factors. This can be of two types which are catabolism and anabolism. Metabolomics is a study of chemical reactions related to metabolites and a field of analytical biochemistry. Metabolomics is used to compute and recognize the metabolites present in the cell via analytical technologies together with a multi-variant and statistical method for data interpretation.

There are some factors which enable the market to grow and some which enables to restraint the market. The driving factors are increasing demand for metabolomics in drug discovery and personalized medicine and rise in the funding and investment by the government. For instance, the application of metabolomics is growing in the biomedical domain. This is particularly used to diagnose disease, understand disease mechanisms, identify novel drug targets, customize drug treatments and monitor therapeutic outcomes. There are also some latest technological advances in metabolomics, focusing on the application of metabolomics towards uncovering the underlying causes of complex diseases (such as atherosclerosis, cancer, and diabetes), the growing role of metabolomics in drug discovery and its potential effect on precision medicine. The great opportunity for personalized medicine is its possibility to introduce novel scientific, business, and medical models.

There is a high prevalence of chronic degenerative diseases such as cardiovascular diseases, neurodegenerative disorders, cancer, and others in developed countries. Factors such as unhealthy dietary habits, sedentary lifestyles, and habits such as smoking and alcohol consumption are additionally contributing to the increase in obesity, diabetes, heart disease, stroke, and other medical disorders, especially in developing countries. With the growing unmet medical needs, the importance of personalized medicine is rising across the globe. With the increase in the demand for personalized medicines, the demand for metabolomics is expected to increase across the globe.

There are many companies providing metabolomics technology such as B SCIEX, LLC, Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Chenomx Inc., Evotec AG, Giotto Biotech S.r.l., Human Metabolome Technologies Inc., and LECO Corp. among various others. Some of the major players of the market are Biocrates Life Sciences AG, Bruker Corp. Shimadzu Corp., and Thermo Fisher Scientific Inc. For instance, Thermo Fisher Scientific Inc. provides metabolomics instruments which are mass spectrometry which is categorized into Liquid Chromatography-Mass Spectrometry (LC-MS), Gas Chromatography-Mass Spectrometry (GC-MS), Inductively Coupled Plasma Mass Spectrometry (ICP-MS) Ion Chromatography-Mass Spectrometry (IC-MS), Isotope Ratio Mass Spectrometry (IRMS), Glow Discharge Mass Spectrometry (GD-MS), Process Mass Spectrometers (PMS), and Mass Spectrometry Software. LC-MS is enabled in identifying unknown compounds even in the complex matrices.

Moreover, ICP-MS is used to identify as well as characterize organic and inorganic samples at ppm to sub-ppt levels. These products are marketed under the brand name TSQ Altis, iCAP, TSQ, and Pierce. In April 2019, the company added two mass spectrometer products in its portfolio which are TSQ Altis MD Series and Quantis MD Series. Bruker Corp. added innovative mass spectrometry solutions in its portfolios such as Trapped Ion Mobility (TIMS), smart beam and scanning lasers for MALDI-MS Imaging. For instance, Agilent Technologies, Inc. has launched a wide range of systems, software, and technologies to improve both mass spectrometry speed and accuracy, which will boost Agilent Technologies, Inc.’s market share.

Request a free sample of our report on Global Metabolomics Technology Market: https://www.omrglobal.com/request-sample/metabolomics-technology-market

About Orion Market Research

Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, company profiling, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +1 646-755-7667, +91 780-304-0404

Like it? Share it!


Rishabh

About the Author

Rishabh
Joined: June 18th, 2019
Articles Posted: 354

More by this author